<DOC>
	<DOCNO>NCT02258048</DOCNO>
	<brief_summary>This prospective study design examine role transient elastography predictor clinical decompensation patient early cirrhosis . The study objective determine change measurement liver stiffness transient elastography identify patient rapid progression cirrhosis development clinical decompensation . The target population patient early stage , well-compensated cirrhosis . Participants study ask complete following procedure : read sign informed consent , medical record review ( complete medical history , physical examination , laboratory evaluation , endoscopic finding , radiographic finding ) , undergo transient elastography measure liver stiffness every three month development clinical decompensation ( ascites , variceal bleeding , hepatorenal syndrome , overt hepatic encephalopathy ) 2 year .</brief_summary>
	<brief_title>The Use Transient Elastography Predict Clinical Decompensation Patients With Early Cirrhosis</brief_title>
	<detailed_description>This prospective study design examine role transient elastography predictor clinical decompensation patient early cirrhosis . The study objective determine change measurement liver stiffness transient elastography identify patient rapid progression cirrhosis development clinical decompensation . The target population patient early stage , well-compensated cirrhosis . This study attempt determine serial measurement liver stiffness transient elastography patient early cirrhosis identify patient risk morbidity mortality associate hepatic decompensation . For Screening Visit , follow procedure perform : 1 . Patient read sign inform consent . Subjects give sufficient time consider , ask question , sign consent form . 2 . Patient assign subject number 3 . Patient ask provide demographic information 4 . Patient ask provide complete medical history laboratory evaluation 5 . Physical examination include blood pressure , heart rate , height , weight . 6 . The following assessment also perform : - Calculation modify Child Pugh Score : Using follow biochemical variable : Serum Albumin , Total Bilirubin , Serum Creatinine , INR . - MELD Score : Based continuous function Bilirubin , INR , Creatinine , use continuous variable range 6-40 . 7 . 30cc blood obtain , serum frozen -80C ( freezer locate Dr. Sigal 's office ) 5 year . The blood accessible Dr. Sigal research team . This blood may analyse know marker liver disease , marker may discover future , and/or identify new marker liver disease . For Follow-Up Visits follow procedure perform every 3 month 2 year : 1 . An interim medical history obtain , particular attention development clinical decompensation ( ascites , variceal bleed hepatorenal syndrome , overt hepatic encephalopathy ) . 2 . Physical examination . 3 . Measurement liver stiffness use hepatic elastography . 4 . 30cc blood obtain , serum frozen future analysis .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>Ambulatory patient histologic radiographic evidence cirrhosis screen participation study . Able provide inform consent MELD score &lt; 10 No history ascites , variceal bleeding , hepatorenal syndrome , overt hepatic encephalopathy . History variceal bleeding , ascites , hepatorenal syndrome , overt hepatic encephalopathy Inability provide inform consent Body mass index ( BMI ) &gt; 35</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Cirrhosis</keyword>
</DOC>